Results 231 to 240 of about 361,230 (299)

Sex as a biological variable in nonclinical studies: Bridging scientific rigor, animal welfare, and regulatory expectations

Animal Models and Experimental Medicine, EarlyView.
Sex as a biological variable (SABV) is a critical determinant of pharmacokinetics, pharmacodynamics, and toxicity in nonclinical studies. This review highlights how inappropriate neglect of sex differences compromises animal welfare, scientific reproducibility, and regulatory compliance.
Kenta Onuma, Masaki Watanabe, Nobuya Sasaki   +2 more
wiley   +1 more source

Smart decision framework for financial planning and investment optimization. [PDF]

Sci Rep
Chen X, Shen A.
europepmc   +1 more source

Animal research in the UK: Regulation, implementation, welfare and development of new approach methodologies

Animal Models and Experimental Medicine, EarlyView.
Scientific research with animals in the UK is regulated by the Animals (Scientific Procedures) Act 1986 with the National Centre for the Replacement, Refinement and Reduction of Animals in Research providing support for best practice and facilitating development of new approach methodologies.
Ewan St. John Smith, James Bussell, Maggie Gentry, Elliot Lilley, Cathy Merry, Judy MacArthur Clark, William Reynolds   +6 more
wiley   +1 more source

The impact of tokenization on the trading process costs and carbon emission: Empirical study on the ODDO BHF Bond. [PDF]

Carbon Balance Manag
Belkhiria S, Abid E, Khiari W.
europepmc   +1 more source

Embedding Chemistry and Pharmacy Into Sustainability

Angewandte Chemie International Edition, EarlyView.
Chemistry and pharmacy provide products and processes that are indispensable for our high living standard. To understand their relationship with sustainability is important to allow them to contribute to sustainability in a sustainable manner. An integrated overview of green, circular, and sustainable chemistry and pharmacy is given and how they have t
Klaus Kümmerer
wiley   +1 more source

Investment attractiveness in BRICS+ economies: Evaluating business environment reforms, institutional quality, and macroeconomic factors. [PDF]

PLoS One
Tachega MA, Wang J, Chen Y, Ahmed R, Opoku EO, Mintah C, Bart-Plange L.   +6 more
europepmc   +1 more source

Capitalising (on) industrial epidemics: examining the influence of the 'Big Three' asset managers on corporate governance in key health-harming commodity industries. [PDF]

Global Health
Wood B, Slater S, Friel S, Schram A, Frank N, Sacks G.   +5 more
europepmc   +1 more source

Do ESG Frameworks Capture Corporate Health Impacts? An Analysis of the Food and Beverage Industry. [PDF]

Int J Environ Res Public Health
Burgess R, Chen K, Kim SJ, Dharia N, Lin C, Srebotnjak T, Grierson L, Freudenberg N, Esty DC, Ransome Y.   +9 more
europepmc   +1 more source

Green investors and ESG ratings divergence. [PDF]

Sci Rep
Ge Y, Zhang R, Zhu H.
europepmc   +1 more source

Unlocking private finance for nature: Addressing barriers and reframing risk-return dynamics. [PDF]

iScience
Sheikh HA, Narain D, Bartlett C, Christiaen C.   +3 more
europepmc   +1 more source